DE60316970D1 - Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren - Google Patents

Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren

Info

Publication number
DE60316970D1
DE60316970D1 DE60316970T DE60316970T DE60316970D1 DE 60316970 D1 DE60316970 D1 DE 60316970D1 DE 60316970 T DE60316970 T DE 60316970T DE 60316970 T DE60316970 T DE 60316970T DE 60316970 D1 DE60316970 D1 DE 60316970D1
Authority
DE
Germany
Prior art keywords
chitinoles
sulfated
polymers
drug processing
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316970T
Other languages
English (en)
Other versions
DE60316970T2 (de
Inventor
Agis Kydonieus
Clive Elson
Maya Thanou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kytogenics Pharmaceuticals Ltd
Original Assignee
Chitogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chitogenics Inc filed Critical Chitogenics Inc
Publication of DE60316970D1 publication Critical patent/DE60316970D1/de
Application granted granted Critical
Publication of DE60316970T2 publication Critical patent/DE60316970T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60316970T 2002-08-20 2003-08-07 Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren Expired - Lifetime DE60316970T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/224,173 US7265097B2 (en) 2002-08-20 2002-08-20 Methods of drug delivery using sulphated chitinous polymers
US224173 2002-08-20
PCT/US2003/024769 WO2004018010A2 (en) 2002-08-20 2003-08-07 Methods of drug delivery using sulphated chitinous polymers

Publications (2)

Publication Number Publication Date
DE60316970D1 true DE60316970D1 (de) 2007-11-29
DE60316970T2 DE60316970T2 (de) 2008-07-17

Family

ID=31886764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316970T Expired - Lifetime DE60316970T2 (de) 2002-08-20 2003-08-07 Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren

Country Status (7)

Country Link
US (2) US7265097B2 (de)
EP (1) EP1546216B1 (de)
AT (1) ATE376004T1 (de)
AU (1) AU2003256882A1 (de)
CA (1) CA2496376C (de)
DE (1) DE60316970T2 (de)
WO (1) WO2004018010A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7691830B2 (en) * 2005-02-17 2010-04-06 Clive Elson Method and composition for treatment of a mucosal tissue disorder
US20060257355A1 (en) * 2005-05-10 2006-11-16 Abiomed, Inc. Impregnated polymer compositions and devices using them
US20080085331A1 (en) * 2006-10-06 2008-04-10 Gluskin Anna E Composition and method for raising blood glucose level
PL2205623T3 (pl) * 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
BRPI0801422B8 (pt) * 2008-03-26 2021-05-25 Fund Sao Francisco Xavier composição e método para inibição da severidade das aderências pós-cirúrgicas
DK2321640T3 (en) 2008-08-21 2017-02-27 Immunogenics Llc FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS
CN102711463B (zh) 2009-12-03 2015-05-13 Opko健康公司 超硫酸化双糖制剂
EP3417865A1 (de) * 2011-07-19 2018-12-26 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung nicht-antikoagulierender sulfatierter polysaccharide

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4301067A (en) * 1979-06-05 1981-11-17 Kureha Kagaku Kogyo Kabushiki Kaisha Chitin containing poly-ion complex
US4424346A (en) 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
US4570629A (en) 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
US4659700A (en) 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
US4619913A (en) 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
SE456346B (sv) 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
US4619995A (en) 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
US4868113A (en) 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
US5460939A (en) 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US4946870A (en) 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US4819617A (en) 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
US5080893A (en) 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US4978332A (en) 1987-09-28 1990-12-18 Matrix Pharmaceutical, Inc. Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
DK505488D0 (da) 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
US5140016A (en) 1988-05-31 1992-08-18 University Of Florida Method and composition for preventing surgical adhesions using a dilute solution of polymer
US5470829A (en) 1988-11-17 1995-11-28 Prisell; Per Pharmaceutical preparation
US5234915A (en) 1989-03-09 1993-08-10 Micro Vesicular Systems, Inc. Biodegradable gel
US5093319A (en) 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5412084A (en) 1991-10-09 1995-05-02 Nova Chem Limited N-O-carboxymethylchitosonium carboxylate salts
AU3235593A (en) 1991-12-20 1993-07-28 Howmedica Inc. Process for insolubilizing N-carboxyalkyl derivatives of chitosan
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
JPH06211903A (ja) * 1993-01-19 1994-08-02 Shin Etsu Chem Co Ltd 硫酸化キトサンの製造方法およびキトサンの硫酸化剤
EP0637450A3 (de) 1993-08-04 1995-04-05 Collagen Corp Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe.
US5411988A (en) 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
DE4337152A1 (de) 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
EP0665022A1 (de) 1994-01-28 1995-08-02 Prodex, Inc. Viskoelastische Lösung aus N,O-Carboxymethylchitosan zur opthalmischen Verwendung
GB9421653D0 (en) 1994-10-27 1994-12-14 Innovative Tech Ltd Wound dressing
GB9421969D0 (en) 1994-10-28 1994-12-21 Innovative Tech Ltd Wound treatment composition
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5679658A (en) 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第4因子の製造方法
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
US6730735B2 (en) * 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
WO2001010421A1 (en) * 1999-08-06 2001-02-15 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
EP1095650A1 (de) 1999-10-29 2001-05-02 Universiteit Leiden Zweiphasensystem mit kontrollierter Freigabe
WO2003086297A2 (en) * 2002-04-08 2003-10-23 Lavipharm Laboratories, Inc. Multi-layer mucoadhesive drug delivery device with bursting release layer
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers

Also Published As

Publication number Publication date
US20040038870A1 (en) 2004-02-26
US8017595B2 (en) 2011-09-13
EP1546216A2 (de) 2005-06-29
DE60316970T2 (de) 2008-07-17
WO2004018010A3 (en) 2004-07-08
AU2003256882A8 (en) 2004-03-11
AU2003256882A1 (en) 2004-03-11
WO2004018010A2 (en) 2004-03-04
US7265097B2 (en) 2007-09-04
CA2496376C (en) 2013-05-07
US20080076704A1 (en) 2008-03-27
CA2496376A1 (en) 2004-03-04
ATE376004T1 (de) 2007-11-15
EP1546216A4 (de) 2006-05-10
EP1546216B1 (de) 2007-10-17

Similar Documents

Publication Publication Date Title
ATE541597T1 (de) Implantierbare vorrichtung mit sich langsam auflösendem polymer
TW200728329A (en) Preparation and application of high refraction polymers
DK1866324T3 (da) Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer
ATE458021T1 (de) Biologisch abbaubare kationische polymere
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
ATE474617T1 (de) Medizinproduktsysteme
BRPI0509366A (pt) método para remover potássio de um indivìduo animal, formulação farmacêutica, métodos para tratar uma doença e para determinar uma permeabilidade de casca a um ìon, composição farmacêutica, composição de núcleo-casca,e, método para sintetizar um polìmero de alfa-fluroacrilato
ATE494012T1 (de) Stabilisierte polymer-thiol-reagenzien
BR0309297A (pt) Artigo retrorreflexivo , e, método de preparar o mesmo
CY1105877T1 (el) Οφθαλμικες συνθεσεις πepιεχουσες συνepγιστικο συνδυασμο τριων πολυμepων
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DK1585470T3 (da) Transdermal afgivelse af fentanyl
ATE417833T1 (de) Triazinderivate mit carbamatfunktion
DK1543063T3 (da) Medikament levering
EP1957256A4 (de) Verfahren zur lösung eines präparats aus polymeren der polyolefinklasse zur elektrospinning-verarbeitung
DE60316970D1 (de) Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren
DE502007003845D1 (de) Verfahren zur behandlung von oberflächen
WO2019055996A8 (en) Polymer nanodiscs for biotechnology and medical applications
ATE430771T1 (de) Modifizierung von thermoplastischen polymeren
DE60312425D1 (de) Polymerisierbare Verbindung, Polymerverbindung und Blockcopolymerverbindung und Zusammensetzung; Verfahren zur Bildherstellung und Bilderzeugungsgerät, das dieses verwendet
DE602007005146D1 (de) Ammensetzung
AR062544A1 (es) Composicion antiestatica util para la polimerizacion o copolimerizacion de olefinas en suspension proceso de polimerizacion o copolimerizacion y de olefinas en suspension y polimeros o copolimeros en olefinas
ATE495752T1 (de) Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten
ATE497991T1 (de) Phosphitester enthaltende stabilisatorzusammensetzung
ATE494331T1 (de) Poly(arylenether)zusammensetzung, verfahren und gegenstand

Legal Events

Date Code Title Description
8364 No opposition during term of opposition